Conference Coverage

Platinum Levels Linked to Toxicity in Testicular Cancer Survivors


 

AT THE ANNUAL MEETING OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY

The study is "very interesting and provocative," Dr. Margolin concluded, "but we need more data. Pharmacologic investigations are still needed to enhance the quality of life for this growing number of germ cell tumor survivors."

Although the study focused on serum, Dr. Boer noted that platinum can be found in other tissues as well. "In the ganglia, for example, and also in bone, fat, and the liver ... it’s ... not really known if the platinum in these body compartments is reactive or not. It is really a topic that deserves more research," he said.

Dr. Boer disclosed that he had no relevant conflicts of interest. Dr. Margolin disclosed that she is a consultant to Bristol-Myers Squibb, Genentech, and Johnson & Johnson.

Pages

Recommended Reading

Technology Trumps Outcomes in Prostate Cancer Reimbursement
MDedge Internal Medicine
Prostate Cancer Survivors Avoid Therapy for Sexual Side Effects
MDedge Internal Medicine
NICE Reverses Course on Abiraterone
MDedge Internal Medicine
U.S. Task Force Confirms Stance Against Universal PSA Screening
MDedge Internal Medicine
PSA Level Could Determine Screening Frequency in 40s
MDedge Internal Medicine
Intermittent Hormone Therapy Shortens Prostate Cancer Survival
MDedge Internal Medicine
OGX-427 Takes Aim at Novel Target in Prostate Cancer
MDedge Internal Medicine
PSA May Be Unreliable in Type 1 Diabetes
MDedge Internal Medicine
FDA Approves REMS for Long-Acting Opioids
MDedge Internal Medicine
Studies Clash on Cardiac Effects of TKIs in Kidney Cancer
MDedge Internal Medicine